NEW YORK, NY / ACCESS Newswire / September 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Spirit Aviation Holdings, Inc.("Spirit" or the "Company") (NYSE:FLYY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Spirit and certain of its officers and/or directors […]

NEW YORK CITY, NY / ACCESS Newswire / September 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Skillz Inc. ("Skillz" or the "Company") (NYSE:SKLZ). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Skillz and certain of its officers and/or directors

NEW YORK CITY, NY / ACCESS Newswire / September 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Agios Pharmaceuticals, Inc. ("Agios" or the "Company") (NASDAQ:AGIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Agios and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / September 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Quanex Building Products Corporation ("Quanex" or the "Company") (NYSE:NX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Quanex and certain of its officers

NEW YORK CITY, NY / ACCESS Newswire / September 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Synopsys, Inc. ("Synopsys" or the "Company") (NASDAQ:SNPS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Synopsys and certain of its officers and/or directors

NEW YORK CITY, NY / ACCESS Newswire / September 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Galiano Gold Inc. ("Galiano" or the "Company") (NYSE:GAU). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Galiano and certain of its officers and/or

NEW YORK, NY / ACCESS Newswire / September 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of aTyr Pharma, Inc. ("aTyr" or the "Company") (NASDAQ:ATYR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether aTyr and certain of its officers and/or directors

NEW YORK CITY, NY / ACCESS Newswire / September 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of MediaAlpha, Inc. ("MediaAlpha" or the "Company") (NYSE:MAX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether MediaAlpha and certain of its officers and/or directors

NEW YORK, NY / ACCESS Newswire / September 26, 2025 / If you suffered a loss on your RCI Hospitality Holdings, Inc. (NASDAQ:RICK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rci-hospitality-holdings-inc-lawsuit-submission-form?prid=169668&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

NEW YORK, NY / ACCESS Newswire / September 26, 2025 / If you suffered a loss on your KBR, Inc. (NYSE:KBR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/kbr-inc-lawsuit-submission-form?prid=169669&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call